인공 주요 장기 및 의료용 바이오닉스 시장 규모, 점유율, 동향에 관한 분석 보고서 : 인공 장기별, 바이오닉스별, 지역별 및 부문별 전망(2026-2033년)

The global artificial vital organs and medical bionics market size was valued at USD 45.0 billion in 2025 and is projected to grow from USD 49.2 billion in 2026 to USD 91.7 billion in 2033, at a CAGR of 9.3% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 44.5% in 2025. Market growth has been driven by several factors, including technological advancements, the rising incidence of disorders, and an aging population. Moreover, increased investment in research and development, as well as the growing number of patients waiting for organ transplants, have contributed to the market's growth. Furthermore, government efforts to ensure patient safety have also stimulated market growth.

Market growth worldwide is driven by a confluence of demographic shifts and technological advancements. The increasing number of individuals over the age of 65, who are more susceptible to organ failure, is a major factor driving demand for organ implants and artificial vital organs. According to the Directorate General of Health Services, India alone has over 1.8 lakh people suffering from renal failure, with only 60,000 receiving transplants, while over 2 lakh people suffer from liver failure or cancer, with only 1,500 transplants performed. As the global population ages, the need for effective solutions to address organ failure has become more pressing, creating opportunities for market players to develop innovative products.

Continuous technological breakthroughs in medical research and biomedical engineering are also contributing to market expansion. The shortage of donor organs for transplantation, which results in lengthy waiting times and limited availability of suitable donors, has created a high demand for artificial vital organs. Furthermore, the rising prevalence of chronic diseases, such as heart disease, diabetes, and kidney disease, which often result in organ failure, is another significant factor contributing to market growth.

Growing healthcare expenditure, particularly in emerging economies, is another driver for market growth. As patients seek to improve their quality of life and extend their lifespan, the adoption of artificial vital organs and medical bionics is increasing. Moreover, positive government actions to protect patient safety standards and research activities, as well as increased awareness of public and private reimbursement coverage, are boosting adoption rates and creating opportunities for market players.

Global Artificial Vital Organs and Medical Bionics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global artificial vital organs and medical bionics market report based on artificial organs, bionics, and region:

• Artificial Organs Outlook (Revenue, USD Billion, 2021 - 2033)

Heart

Kidney

Liver

Pancreas

Lungs

• Bionics Outlook (Revenue, USD Billion, 2021 - 2033)

Ear Bionics

Vision Bionics

Exoskeletons

Bionic Limbs

Brain Bionics

Cardiac Bionics

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

North America

• U.S.
• Canada
• Mexico

Europe

• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway

Asia Pacific

• Japan
• China
• India
• Australia
• South Korea
• Thailand

Latin America

• Brazil
• Argentina

Middle East & Africa

• South Africa
• Saudi Arabia
• UAE
• Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Artificial Vital Organs and Medical Bionics Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Artificial Vital Organs and Medical Bionics Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Artificial Vital Organs and Medical Bionics Market: Artificial Organ Estimates & Trend Analysis

• 4.1. Segment Dashboard
  • 4.1.1. Artificial Vital Organs and Medical Bionics Market: Artificial Organ Movement Analysis, 2023 & 2030 (USD Million)
• 4.2. Heart
  • 4.2.1. Heart Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.3. Kidney
  • 4.3.1. Kidney Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Liver
  • 4.4.1. Liver Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Pancreas
  • 4.5.1. Pancreas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Lungs
  • 4.6.1. Lungs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Artificial Vital Organs and Medical Bionics Market: Bionics Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Artificial Vital Organs and Medical Bionics Market: Bionics Movement Analysis, 2023 & 2030 (USD Million)
• 5.3. Ear Bionics
  • 5.3.1. Ear Bionics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.2. Vision Bionics
  • 5.3.3. Vision Bionics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Exoskeletons
  • 5.4.1. Exoskeletons Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Bionic Limbs
  • 5.5.1. Bionic Limbs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Brain bionics
  • 5.6.1. Brain Bionics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Cardiac Bionics
  • 5.7.1. Cardiac Bionics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Artificial Vital Organs and Medical Bionics Market: Regional Estimates & Trend Analysis

• 6.1. Artificial Vital Organs and Medical Bionics Market Share, By Region, 2023 & 2030 (USD Billion)
• 6.2. North America
  • 6.2.1. North America Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. U.S. Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3. Canada
    • 6.2.3.1. Canada Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.4. Mexico
    • 6.2.4.1. Mexico Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.3. Europe
  • 6.3.1. Europe Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. UK
    • 6.3.2.1. UK Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Germany
    • 6.3.3.1. Germany Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. France
    • 6.3.4.1. France Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.5. Italy
    • 6.3.5.1. Italy Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.6. Spain
    • 6.3.6.1. Spain Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.7. Denmark
    • 6.3.7.1. Denmark Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.8. Sweden
    • 6.3.8.1. Sweden Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.9. Norway
    • 6.3.9.1. Norway Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. China
    • 6.4.2.1. China Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Japan
    • 6.4.3.1. Japan Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. India
    • 6.4.4.1. India Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.5. South Korea
    • 6.4.5.1. South Korea Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.6. Australia
    • 6.4.6.1. Australia Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.7. Thailand
    • 6.4.7.1. Thailand Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1. Brazil Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Argentina
    • 6.5.3.1. Argentina Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Middle East and Africa
  • 6.6.1. Middle East and Africa Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1. South Africa Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Saudi Arabia
    • 6.6.3.1. Saudi Arabia Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. UAE
    • 6.6.4.1. UAE Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Kuwait
    • 6.6.5.1. Kuwait Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
  • 7.4.1. Medtronic, Inc.
    • 7.4.1.1. Participant's Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Recent Developments/Strategic Initiatives
  • 7.4.2. LifeNet Health
    • 7.4.2.1. Participant's Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Recent Developments/Strategic Initiatives
  • 7.4.3. Terumo Corporation
    • 7.4.3.1. Participant's Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Recent Developments/Strategic Initiatives
  • 7.4.4. Ekso Bionics Holdings, Inc.
    • 7.4.4.1. Participant's Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Recent Developments/Strategic Initiatives
  • 7.4.5. Nano Retina Ltd.
    • 7.4.5.1. Participant's Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Recent Developments/Strategic Initiatives
  • 7.4.6. Edwards Lifesciences Corporation
    • 7.4.6.1. Participant's Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Recent Developments/Strategic Initiatives
  • 7.4.7. InnoScot Health Ltd.
    • 7.4.7.1. Participant's Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Recent Developments/Strategic Initiatives
  • 7.4.8. Ottobock SE & Co. KGaA
    • 7.4.8.1. Participant's Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Recent Developments/Strategic Initiatives
  • 7.4.9. Orthofix Medical Inc.
    • 7.4.9.1. Participant's Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Recent Developments/Strategic Initiatives